Most patients with hepatocellular carcinoma are not eligible for surgery at the time of primary diagnosis. Portal vein thrombosis is frequent and represents a contraindication for transarterial chemoembolisation. Transarterial therapy with iodine-131-Lipiodol is superior to systemic therapy in tumours up to diameters of 5 cm and may be performed even in cases with portal vein thrombosis. Compared to other intraarterial therapy procedures, iodine-131-Lipiodol shows the same efficacy but less side effects.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
portal vein
8
vein thrombosis
8
therapy
4
therapy hepatocellular
4
hepatocellular cancer
4
cancer iodine-131-lipiodol
4
iodine-131-lipiodol patients
4
patients hepatocellular
4
hepatocellular carcinoma
4
carcinoma eligible
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!